» Articles » PMID: 29118049

The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota

Abstract

The human gut microbiota is engaged in multiple interactions affecting host health during the host's entire life span. Microbes colonize the neonatal gut immediately following birth. The establishment and interactive development of this early gut microbiota are believed to be (at least partially) driven and modulated by specific compounds present in human milk. It has been shown that certain genomes of infant gut commensals, in particular those of bifidobacterial species, are genetically adapted to utilize specific glycans of this human secretory fluid, thus representing a very intriguing example of host-microbe coevolution, where both partners are believed to benefit. In recent years, various metagenomic studies have tried to dissect the composition and functionality of the infant gut microbiome and to explore the distribution across the different ecological niches of the infant gut biogeography of the corresponding microbial consortia, including those corresponding to bacteria and viruses, in healthy and ill subjects. Such analyses have linked certain features of the microbiota/microbiome, such as reduced diversity or aberrant composition, to intestinal illnesses in infants or disease states that are manifested at later stages of life, including asthma, inflammatory bowel disease, and metabolic disorders. Thus, a growing number of studies have reported on how the early human gut microbiota composition/development may affect risk factors related to adult health conditions. This concept has fueled the development of strategies to shape the infant microbiota composition based on various functional food products. In this review, we describe the infant microbiota, the mechanisms that drive its establishment and composition, and how microbial consortia may be molded by natural or artificial interventions. Finally, we discuss the relevance of key microbial players of the infant gut microbiota, in particular bifidobacteria, with respect to their role in health and disease.

Citing Articles

Probiotic Bifidobacterium bifidum strains desialylate MUC13 and increase intestinal epithelial barrier function.

Segui-Perez C, Huang L, Paganelli F, Lievens E, Strijbis K Sci Rep. 2025; 15(1):8778.

PMID: 40082523 PMC: 11906825. DOI: 10.1038/s41598-025-92125-2.


Dietary Pea Fibre Improves Obesity, Intestinal Barrier, Reproductive Performance, Offspring Health of Parent Mice Deprived of Dietary Fibre.

Tian S, Zhang M, Chen Y, Sun H, Li Q, Yang Y Animals (Basel). 2025; 15(5).

PMID: 40075937 PMC: 11898131. DOI: 10.3390/ani15050655.


Fecal microbiota transplantation for the treatment of intestinal and extra-intestinal diseases: Mechanism basis, clinical application, and potential prospect.

Yi D, Li T, Xiao Y, Zhang X, Hao Q, Zhang F Bioeng Transl Med. 2025; 10(2):e10728.

PMID: 40060755 PMC: 11883108. DOI: 10.1002/btm2.10728.


Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer.

Zhang H, Tian Y, Xu C, Chen M, Xiang Z, Gu L Cell Death Discov. 2025; 11(1):78.

PMID: 40011436 PMC: 11865559. DOI: 10.1038/s41420-025-02364-5.


Animal Models for Studying Developmental Origins of Cardiovascular-Kidney-Metabolic Syndrome.

Tain Y, Lin Y, Hsu C Biomedicines. 2025; 13(2).

PMID: 40002865 PMC: 11853432. DOI: 10.3390/biomedicines13020452.


References
1.
Lee J, OSullivan D . Genomic insights into bifidobacteria. Microbiol Mol Biol Rev. 2010; 74(3):378-416. PMC: 2937518. DOI: 10.1128/MMBR.00004-10. View

2.
Fouhy F, Ross R, Fitzgerald G, Stanton C, Cotter P . Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes. 2012; 3(3):203-20. PMC: 3427213. DOI: 10.4161/gmic.20169. View

3.
Lagier J, Khelaifia S, Alou M, Ndongo S, Dione N, Hugon P . Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol. 2016; 1:16203. DOI: 10.1038/nmicrobiol.2016.203. View

4.
NAEYE R, Peters E . Causes and consequences of premature rupture of fetal membranes. Lancet. 1980; 1(8161):192-4. DOI: 10.1016/s0140-6736(80)90674-1. View

5.
Baeten J, Bukusi E, Lambe M . Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001; 91(3):436-40. PMC: 1446581. DOI: 10.2105/ajph.91.3.436. View